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with 'H nuclear magnetic resonance
(NMR) technique using an internal con-
trol (5). Blood samples from animals given
feed without siloxanes showed no signals
originating from the silicones tested. In all
blood samples from animals given feed
with siloxanes, they were detected. In sam-
ples from animals given feed with PDMS,
the mean concentration (± standard devia-
tion) of siloxanes of 26 ± 14 pg/cm3 was
noted; in samples from animals given feed
with cPDMS, the mean concentration of
siloxanes of 70 ± 97 pg/cm3 was noted.
The difference was not significant. These
results conform well to those obtained pre-
viously in Rhesus monkeys by Calandra et
al. (6). In our opinion, the absorption and
toxicity of siloxane-based drugs should be
more intensively studied.
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In their recent publication, Lieberman et
al. (1) described the acute toxicity in mice
after intraperitoneal injection of distillates
containing either a mixture of cyclosilox-
anes or a component ofthe mixture's distil-
late (octamethylcyclotetrasiloxane). The
dose levels in the series of studies ranged
from 3.5 to 35 g/kg. The median lethal
dose of the distillate was 28 g/kg, or 1.68
kgfor a60-kghuman.
The authors drew sweeping conclusions
regarding this class ofchemicals based on a
minimalist investigation of toxicity. The
acute doses administered by the intraperi-
toneal route were clearly excessive and were
much greater than the limit doses recom-
mended by the U.S. Environmental
Protection Agency (EPA) and the
Organisation for Economic Co-operation
and Development (OECD) as maximum
dose levels in studies ofthis type. Few com-
pounds are tested at dose levels this high
because of concerns regarding unnecessary
pain and suffering ofanimals. A basic tenet
of toxicology is that all chemicals have the
potential to be toxic atsufficiendy high dose
levels. The toxicity observed after adminis-
tering extremely high dose levels is not use-
ful for comparative purposes (because few
compounds are tested at such high levels) or
for risk assessment (because the dose levels
are so much greater than potential human
exposures to the agents ofconcern). Acute
lethal studies conducted by the intraperi-
toneal route deliver a bolus dose with the
equivalent of 100% absorption. Lethality is
not a surprising finding under these condi-
tions and would be observed with table salt
and other substances generally considered to
be innocuous.
Furthermore, the conclusion that cyclic
siloxanes are similar in toxicity to carbon
tetrachloride and trichloroethylene is
unfounded. The no-observed-adverse-effect
level (a standard benchmark oftoxicity) for
carbon tetrachloride that has been used to
set a drinking water standard is 1.0
mg/kg/day in a 12-week gavage study in
rats (2). This was 3,500 times less than the
lowest level used by Lieberman and col-
leagues (1). They did not present any evi-
dence that carbon tetrachloride and
trichloroethylene share a common mecha-
nism oftoxicitywith the siloxanes.
In summary, the publication of
Lieberman et al. (1) does not advance our
understanding ofthe toxicity ofthis class of
compounds. The paper is likely to be cited
by plaintiffs in tort cases, but the study
results are oflimited use to those ofus who
are concerned with the safety evaluation
and risk assessment ofthese substances.
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I recently read the paper "Cyclosiloxanes
Produce Fatal Liver and Lung Damage in
Mice" (1). Although siloxanes are not a par-
ticular interest of mine, I was curious.
Lieberman et al. (1) administered the dis-
tilled mix at a rate of 3.5-35 g/kg body
weight. As a toxicologist, I was intrigued
because 35 g/kg is 3.5% of body weight,
injected intraperitoneally yet! Toxicolog-
ically, such a dose is akin to hitting the
mouse with a stick. Lieberman et al. report-
ed that "some or all of the components of
the distillate are lethal, with an LD50 for the
distillate ofabout 28 g/kg." Do we ever find
a substance that is not lethal at some dose?
Lieberman et al. (1) then make the fol-
lowing statement:
Our data demonstrate that a mixture of low-
molecular-weight CSs contained in breast
implants is highly toxic and that at least one spe-
cific compound, CS-D4, is toxic as well.
Highly toxic indeed!
Five grams per kilogram is usually con-
sidered virtually nontoxic in the world of
pesticides, and here we are told that 28
g/kg is highly toxic. CS-D4 comes a bit
closer at 6-7 g/kg. There appears to be a
three-order-of-magnitude nomenclature
problem here.
The finding ofhydroxyl radical forma-
tion as a result of treatment with CS-D4
sparked a moment of interest, which died
when I saw that the animals were given a
lethal dose, and no dose-response informa-
tion was obtained. [Lieberman et al.'s
Figure 4 (1) does not disclose the dose, but
itwas found in text, fortunately nearby.]
It also occurred to me that there was
some missing context. Lieberman et al. (1)
did not explain what fraction ofan implant
actually can be extracted in such a distillate,
even though they quoted an earlier paper
with that information (2). Approximately
1% of the implant can be considered
mobile, if distillation describes mobility.
Mobilization in vivo is obviously slow,
unlike the intraperitoneal assault on the
mice.
I am curious about the point of this
paper. I do not follow the implant prob-
lem, but I know that it is highly charged
politically and emotionally. As the newspa-
pers tell us, implants are litogenic and pro-
duce much exercise for the courts. The
only conclusion I can draw is that the ter-
minology here is political. It is the kind of
rhetoric that comes from activists who
ignore science.
It is important to learn what happens
to this foreign material placed in the body
and to try to track the biological interac-
tions. Lieberman et al. (1) make a small
contribution, but I predict that this paper
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will be dreadfully misused. I also have
other concerns about the work. If I had I
been a reviewer, I would have considered
this paper publishable only ifthe language
and implications were modified.
Perhaps of greatest importance, this
paper does not create confidence in EHP
there seems to have been a lack ofdiligence
in the review of this manuscript. EHP
should be a flagship among journals, but
poor reviewing will set it adrift.
Frank N. Dost
Freeland, Washington
E-mail: jfdost@whidbey.com
REFERENCES AND NOTES
1. Lieberman MW, Lykissa ED, Barrios R, Ou CN, Kala
G, Kala SV. Cyclosiloxanes produce fatal liver and
lung damage in mice. Environ Health Perspect
107:161-165 (1999).
2. Kala SV, Lykissa ED, Neely MW, Lieberman MW.
Low molecular weight silicones are widely distrib-
uted after a single subcutaneous injection in mice.
Am J Pathol 152(3):645-649(1998).
Response from Lieberman
and Colleagues
Several of the scientists who responded to
our paper (1) raised similar questions, most-
ly showing a concern about the high doses
used in our study. However, we would like
to point out that, to the best ofour knowl-
edge, our paper is the first to examine the
LD50 of cyclosiloxanes (CSs). While there
may be a difference of opinion about the
interpretation of these data, for the first
time there are data to discuss. Of equal
importance is that we provide data on doses
lower than the LD50. These data demon-
strate elevated serum enzyme values and
histopathologic changes following adminis-
tration of CSs and CS-D4 at nonlethal
doses (0.1 mL/mouse; - 3.5 g/kg). All of
these considerations underscore the value of
our work. Other studies have used similar
doses and the same route ofadministration
(0.1-lmL intraperitoneally) to examine the
toxicity of organic compounds including
siloxanes (2-4). In our studies, no effects
were noted when 1 mL soy oil was adminis-
tered as a control. Our studies were intend-
ed to examine the acute toxicity of these
agents rather than to evaluate their chronic
toxicity or to determine the minimal level at
which theyproduced a toxic effect.
Another concern raised by readers was
the comparison of cyclosiloxanes with car-
bon tetrachloride (CC14) and trichloroeth-
ylene. We included this discussion to darify
the fact that even though the LD50 for CS-
D4 is high (-7 g/kg), it falls in the range
of known toxic organic solvents such as
CC14 and trichloroethylene (2). Both CC14
and trichloroethylene have been used at
gram levels to study their acute toxicity by
intraperitoneal injection (2,5,6). Witschi
states that CC14 is moderately toxic and
trichloroethylene is relatively nontoxic.
However, the Agency for Toxic Substances
and Disease Registry (ATSDR) has pub-
lished profiles on the toxicity ofthese com-
pounds and the potential human exposure
and health hazards of these solvents (5,6).
In these documents they note that the max-
imum contaminant level (MCL) for each of
these compounds in drinking water is 5
jpg/L. Because CSs and these organic sol-
vents have similar LD50 values in the gram
per kilogram range, it is possible that after
thorough study of the toxicity of the CSs,
similar MCLs may be set. In addition,
trichloroethylene has been identified
among the top 20 hazardous materials on
the 1997 ATSDR priority list (ranked 15)
(7). This fact emphasizes that compounds
with LD values in this range are impor-
tant pubfic health concerns. Clearly there is
considerable variation in the verbal descrip-
tors ofthe toxicityofthese compounds.
The point is raised that CSs show about
the same acute toxicity as alcohol and sodi-
um chloride and that these chemicals are
freely available in most homes. The pre-
sumption is that, for this reason, we should
have minimal concern about the toxicity of
CSs. Yet we know that analysis of ethyl
alcohol and sodium chloride has led to the
opposite conclusion. Ethyl alcohol is an
important liver toxicant, and many people
worldwide suffer from liver disease as a
result of chronic ethyl alcohol ingestion.
Fetal alcohol syndrome is also well docu-
mented. As for sodium chloride, the rela-
tionship between ingestion ofhigh amounts
ofsalt and high blood pressure and stroke is
well known. We emphasized the need for
additional studies ofCSs in the concluding
two sentences ofour paper:
Further, our studies have not evaluated possible
long-term effects of CSs such as chronic inflam-
mation, chronic pulmonary and liver disease, or
neoplasia. Nevertheless, our results underscore
the importance ofa complete analysis ofthe toxi-
city ofCSs.
Witschi also suggests that the phrase
"cyclosiloxanes are widely distributed" is a
misinterpretation ofour data because only
0.1-0.5% is found in different organs (8).
The term "widely distributed" is used not
as an index ofthe abundance ofCSs in dif-
ferent organs but as a statement of their
presence. We would also like to point out
that we only measured unmetabolized CSs
in these studies. If these compounds were
modified by biotransformation and existed
as new, low-molecular species or bound to
macromolecules, we would not have
detected them by our analysis. Further,
most studies ofsiloxanes until recentlywere
carried out without any quantitative assess-
ment, that is, tissue level ofsiloxanes versus
tissue injury (9). In recognition of this
problem, our group has developed methods
for the detection and quantitation of
cyclosiloxanes in biological tissues (1J).
Carlton and Meeks raise the issue ofthe
preparation of the distillate and the fact
that the "cracking" process at 1800C has no
relationship to breakdown in the intact
implant in vivo. In our paper we made no
inferences about the relationship of distil-
late preparation to breakdown. Rather, we
used the distillation process as a convenient
way to produce a mixture of siloxanes,
which we found migrated out of intact
implants (11). We could have just as easily
purchased the components from a chemical
company, and in fact, that is what we did
with the octamethylcyclotetrasiloxane (CS-
D4). This purchased CS-D4 produced
effects that were indistinguishable from
those ofthe distillate.
Meeks also suggests that these mice
died ofinfection. First, ifthey had died of
infection, this would be an important find-
ing because only mice exposed to the distil-
late or CS-D4 died or developed evidence
of tissue injury. However, the histopatho-
logic picture is not one of infection. The
histopathology ofthe liver showed a classic
pattern of chemically induced cell death,
and the lung lesions were not typical of
bronchopneumonia or lobar pneumonia.
Meeks raises the question of metabo-
lism and clearance. He is accurate that we
do not cite any of the references he has
provided in our discussion. We were in
error in not including the contribution of
McKim et al. (12). The paper was pub-
lished in 1998 and we simply missed it.
All of the other references on CS-D4
metabolism that he cites are abstracts and
not full-length, peer-reviewed articles.
Meeks raises an important point. He
interprets his data to mean that CS-D4 is
metabolized and is rapidly cleared from
the body. While this may be true, never-
theless, many compounds are metabolized
via more than one metabolic pathway;
some of the pathways lead to detoxifica-
tion/inactivation and others lead to active
chemical species that cause tissue injury,
cell death, or neoplasia. The abundant lit-
erature on compounds such as aflatoxin,
benzo(a)pyrene, acetylaminoflurene, and
related compounds provide examples of
this principle. We would also like to point
out that the study Meeks refers to was an
inhalation study, which may not be direct-
ly relevant to our findings.
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